Scienture Holdings, Inc. has entered into a securities purchase agreement with institutional investors.
The offering includes 3,225,000 shares of common stock at $1.20 per share.
Gross proceeds for the offering are expected to be approximately $3.9 million.
Offering Details
3,225,000 shares of common stock at $1.20 per share.
Gross Proceeds
Expected to be approximately $3.9 million.
Placement Agent
Maxim Group LLC is acting as the sole placement agent.
Registration Statement
Offering is pursuant to an effective shelf registration statement on Form S-3.
- The offering is a strategic move to raise capital for Scienture Holdings, Inc.
- It provides institutional investors the opportunity to purchase shares at a set offering price.
The successful completion of the registered direct offering will enhance Scienture Holdings, Inc.'s financial position and support its growth plans in the pharmaceutical industry.